Healthcare | October 05, 2021
Amber Implants VCFix spinal system receives breakthrough designation
The first clinical trial is expected to commence in early 2022 both in Europe and the US
The first clinical trial is expected to commence in early 2022 both in Europe and the US
A total of 707 district hospitals across all states and union territories participated in the performance assessment. The Health Management Information System (HMIS) data for the year 2017–18 has been used as a baseline for this exercise
Lifebit's accompanying suite of AI-powered end-to-end software solutions provide faster data insights, accelerate drug discovery pipelines, and improve clinical trials success
Fortis Memorial Research Institute is the only hospital in India and South Asia to acquire the machine
The global wellness market is valued at more than US $ 1.5 trillion, with annual growth of 5-10 per cent
The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India
Since its inception, over three million users have used MFine services with the platform clocking over three lakh monthly transactions
It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
As part of this strategic partnership, LTI with its digital, technical and life sciences domain capabilities, will help accelerate joint go-to-market pursuits and faster deployment for Clinpal Adopters
Its DirectDetect reagent eliminates RNA extraction for rapid deployment of Covid-19 tests in affected countries
Subscribe To Our Newsletter & Stay Updated
